Question

A nurse is providing care to a client with ovarian cancer prescribed intravenous topotecan. The nurse expects to administer the medication via which venous access site?

Implanted port

PICC

Central line

Peripheral

Answer 1

For the administration of intravenous topotecan in a client with ovarian cancer, an implanted port or a 3. central line is the expected venous access site, due to the necessity for stable, long-term venous access in chemotherapy treatments.

Step-by-step explanation:

The student's question addresses the delivery of intravenous chemotherapeutic agents to a patient with ovarian cancer.

When considering which venous access site is appropriate for the administration of a chemotherapy drug like topotecan, an implanted port or a 3. central line is typically expected given the nature of the drug and the treatment regimen.

Peripheral venous access is generally used for short-term treatments, but chemotherapy often requires stable, long-term access that can tolerate the caustic nature of the drugs.

An implanted port or a central line provides such access and helps reduce the risk of complications associated with frequent needle sticks and peripheral vein damage.